Literature DB >> 11229352

Role of nitric oxide in the regulation of acute and chronic inflammation.

F S Laroux1, D J Lefer, S Kawachi, R Scalia, A S Cockrell, L Gray, H Van der Heyde, J M Hoffman, M B Grisham.   

Abstract

Recent studies by a number of different laboratories have implicated nitric oxide (NO) as an important modulator of a variety of acute and chronic inflammatory disorders. A hallmark of inflammation is the adhesion of leukocytes to post-capillary venular endothelium and the infiltration of leukocytes into the tissue interstitium. Leukocyte adhesion and infiltration is known to be dependent on interaction of the leukocytes with the endothelial cell surface via a class of glycoproteins collectively known as endothelial cell adhesion molecules (ECAMs). Several recent studies suggest that NO may modulate cytokine-induced ECAM expression in cultured endothelial cells in vitro by regulating the activation of nuclear transcription factor kappa B (NF-kappaB). This discussion reviews some of the more recent studies that assess the role of the different NOS isoforms on the inflammatory response in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11229352     DOI: 10.1089/15230860050192161

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  24 in total

Review 1.  The multiple actions of NO.

Authors:  Yuansheng Gao
Journal:  Pflugers Arch       Date:  2009-12-19       Impact factor: 3.657

Review 2.  Reversing age-associated arterial dysfunction: insight from preclinical models.

Authors:  Venkateswara R Gogulamudi; Jinjin Cai; Lisa A Lesniewski
Journal:  J Appl Physiol (1985)       Date:  2018-05-10

3.  Nitric oxide, derived from inducible nitric oxide synthase, decreases hypoxia inducible factor-1alpha in macrophages during aspirin-induced mesenteric inflammation.

Authors:  I Díez; S Calatayud; C Hernández; E Quintana; J E O'Connor; J V Esplugues; M D Barrachina
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

4.  Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection.

Authors:  John E Pearl; Egidio Torrado; Michael Tighe; Jeffrey J Fountain; Alejandra Solache; Tara Strutt; Susan Swain; Rui Appelberg; Andrea M Cooper
Journal:  Eur J Immunol       Date:  2012-09-26       Impact factor: 5.532

5.  Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury.

Authors:  Qing Mei Wang; Timothy J Stalker; Yulan Gong; Yoshiyuki Rikitake; Rosario Scalia; James K Liao
Journal:  Vasc Med       Date:  2012-09-26       Impact factor: 3.239

6.  NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease.

Authors:  Devram Sampat Ghorpade; Akhuri Yash Sinha; Sahana Holla; Vikas Singh; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2013-10-03       Impact factor: 5.157

7.  Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice.

Authors:  Yong Chen; Michael K Boettger; Andreas Reif; Angelika Schmitt; Nurcan Uçeyler; Claudia Sommer
Journal:  Mol Pain       Date:  2010-03-02       Impact factor: 3.395

Review 8.  Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.

Authors:  Jeff S Isenberg; William A Frazier; Murali C Krishna; David A Wink; David D Roberts
Journal:  Curr Drug Targets       Date:  2008-10       Impact factor: 3.465

9.  HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner.

Authors:  Ming Gong; Melinda Wilson; Thomas Kelly; Wen Su; James Dressman; Jeanie Kincer; Sergey V Matveev; Ling Guo; Theresa Guerin; Xiang-An Li; Weifei Zhu; Annette Uittenbogaard; Eric J Smart
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 10.  Stress-hyperglycemia, insulin and immunomodulation in sepsis.

Authors:  Paul E Marik; Murugan Raghavan
Journal:  Intensive Care Med       Date:  2004-02-26       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.